Levobupivacaina Kabi (Levobupivacaine Hydrochloride)

Levobupivacaine works by reversibly blocking voltage‑gated sodium channels on neuronal membranes. This blockade prevents sodium influx, which stops the generation and propagation of action potentials, thereby interrupting nerve signal transmission and producing a reversible loss of sensation in the area supplied by the blocked nerves.

The specific dose of Levobupivacaina Kabi is determined by the prescribing anesthesiologist based on the patient’s age, weight, clinical condition, and the type of procedure. Only a qualified healthcare professional should calculate and administer the appropriate amount.

Safety data for levobupivacaine during pregnancy and lactation are limited. It may be used only when the anticipated benefit to the mother outweighs any potential risk to the fetus or infant, and the decision should be made by the treating physician in consultation with obstetric specialists.

To order Levobupivacaina Kabi, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India supplies hospitals, pharmacies, and procurement teams worldwide, and will request verification of trade or institutional credentials before providing pricing, availability, shipping details, and any necessary import documentation.

Levobupivacaina Kabi contains levobupivacaine, the S‑enantiomer of bupivacaine. It offers comparable anesthetic potency with a lower risk of cardiotoxicity and central nervous system toxicity, making it a preferred choice when a safer safety profile is desired for epidural applications.

Levobupivacaina Kabi should be stored below 25 °C in its original packaging, protected from light and moisture. The solution must be kept in a controlled environment and handled only by trained personnel using aseptic techniques to maintain sterility.

The drug is administered by a qualified anesthesiologist or nurse practitioner via epidural injection. A sterile technique is used to place a catheter or needle into the epidural space, and the calculated dose is then delivered slowly to achieve the desired level of analgesia or anesthesia.

Serious risks include cardiac arrhythmias, seizures, severe respiratory depression, and spinal hematoma. These events are rare but require immediate medical attention. Continuous cardiovascular and neurological monitoring during and after administration helps detect and manage such complications promptly.

Levobupivacaina Kabi should be avoided in patients with known hypersensitivity to levobupivacaine or other amide‑type local anesthetics, those with severe cardiac conduction disorders, uncontrolled epilepsy, or significant coagulopathy that increases the risk of spinal bleeding.